Financial risk and decision-making strategies for lung cancer: insights from Northern Thailand 10.55131/jphd/2026/240102
Main Article Content
Abstract
Lung cancer remains a significant health issue in Northern Thailand, driven by socio-economic factors and environmental pollutants that negatively impact patient outcomes. This study explores the relationship between financial risk, treatment accessibility, and survival rates among lung cancer patients. A total of 290 patients were analyzed concerning their demographics, treatment methods, financial burdens, and outcomes. Utilizing logistic regression and decision curve analysis, a prediction model for financial burden risk was developed, achieving an accuracy of 85.42%, with a sensitivity of 81.82%, and a specificity of 77.97%. Key factors contributing to financial toxicity included irregular income, prior financial difficulties, and inadequate reserve funds. Recommendations for managing patients based on financial risk categories are provided. Low-risk patients can benefit from financial counseling, affordable treatment options, and regular evaluations to mitigate unexpected expenses. Those classified as intermediate risk require timely financial planning, access to support services, and the optimization of healthcare coverage. High-risk patients should receive intensive encouragement through financial assistance programs, multidisciplinary care teams, and palliative care options to alleviate economic stress. The findings highlight the necessity for improved financial assistance policies and integrated care strategies that address financial security, promote environmental wellness, and foster community support, ultimately enhancing treatment adherence and patient outcomes.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Sirisomboon A, Tayanun, G.., Tanskul, N.., Puedtapongpaphanij, S.., Sirisoonthornphibul, T.., Teerakomolwit, C. ., & Chatpaisankun, J.. A Review: Epidemiology and Risk Factors of Lung Cancer patients in Thailand. SciTech Research Journal,. 2024;7(2):155-68.
Nakharutai N, Traisathit P, Thongsak N, Supasri T, Srikummoon P, Thumronglaohapun S, et al. Impact of Residential Concentration of PM2.5 Analyzed as Time-Varying Covariate on the Survival Rate of Lung Cancer Patients: A 15-Year Hospital-Based Study in Upper Northern Thailand. Int J Environ Res Public Health. 2022;19(8).
Pongnikorn D, Daoprasert K, Waisri N, Laversanne M, Bray F. Cancer incidence in northern Thailand: Results from six population-based cancer registries 1993-2012. Int J Cancer. 2018;142(9):1767-75.
Rankantha A, Chitapanarux I, Pongnikorn D, Prasitwattanaseree S, Bunyatisai W, Sripan P, et al. Risk patterns of lung cancer mortality in northern Thailand. BMC Public Health. 2018;18(1):1138.
Nakachi K, Limtrakul P, Sonklin P, Sonklin O, Jarern CT, Lipigorngoson S, et al. Risk factors for lung cancer among Northern Thai women: epidemiological, nutritional, serological, and bacteriological surveys of residents in high- and low-incidence areas. Jpn J Cancer Res. 1999;90(11): 1187-95.
Lelieveld J, Evans JS, Fnais M, Giannadaki D, Pozzer A. The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature. 2015;525(7569): 367-71.
Radmilović-Radjenović M, Sabo M, Prnova M, Šoltes L, Radjenović B. Finite Element Analysis of the Microwave Ablation Method for Enhanced Lung Cancer Treatment. Cancers (Basel). 2021;13(14).
International Agency for Research on Cancer. Global cancer observatory. 2024.
Bizuayehu HM, Dadi AF, Ahmed KY, Tegegne TK, Hassen TA, Kibret GD, et al. Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates. Cancer. 2024;130(21):3708-23.
Sukkhum S, Lim A, Ingviya T, Saelim R. Seasonal Patterns and Trends of Air Pollution in the Upper Northern Thailand from 2004 to 2018. Aerosol and Air Quality Research. 2022;22(5):210318.
Prapa P, Papathanasiou IV, Bakalis V, Malli F, Papagiannis D, Fradelos EC. Quality of Life and Psychological Distress of Lung Cancer Patients Undergoing Chemotherapy. World J Oncol. 2021;12(2-3):61-6.
Chiou L-J, Lin Y-Y, Lang H-C. Effects of Symptom Burden on Quality of Life in Patients with Lung Cancer. Current Oncology. 2024;31(10):6144-54.
Anggondowati T, Ganti AK, Islam KMM. Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database. Translational Lung Cancer Research. 2020;9(4): 1202-11.
Mahesh PA, Archana S, Jayaraj BS, Patil S, Chaya SK, Shashidhar HP, et al. Factors affecting 30-month survival in lung cancer patients. Indian J Med Res. 2012;136(4):614-21.
Arends J. Malnutrition in cancer patients: Causes, consequences and treatment options. European Journal of Surgical Oncology. 2024;50(5): 107074.
Fitch MI, Longo CJ. Emerging Understanding About the Impact of Financial Toxicity Related to Cancer: Canadian Perspectives. Seminars in Oncology Nursing. 2021;37(4):151174.
Longo CJ, Maity T, Fitch MI, Young JT. Patient and Family Financial Burden in Cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada. Current Oncology. 2024;31(5):2713-26.
Nicoll I, Lockwood G, Fitch MI. Perspectives of Cancer Survivors with Low Income: A Content Analysis Exploring Concerns, Positive Experiences, and Suggestions for Improvement in Survivorship Care. Current Oncology. 2023;30(9):8134-48.
He S, Li H, Cao M, Sun D, Yang F, Yan X, et al. Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China. Transl Lung Cancer Res. 2022;11(8):1591-605.
American Cancer Society. Lung Cancer Survival Rate [Internet]. 2024; 2024 [updated 29 January, 2024. Available from: https://www.cancer.org/cancer/ types/lung-cancer/detection-diagnosis-staging/survival-rates.html.
Khan HM, Ramsey S, Shankaran V. Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions. Journal of Clinical Oncology. 2023;41(16):3051-8.
Abrams HR, Durbin S, Huang CX, Johnson SF, Nayak RK, Zahner GJ, et al. Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med. 2021;11(11):2043-54.
Collado L, Brownell I. The crippling financial toxicity of cancer in the United States. Cancer Biol Ther. 2019; 20(10):1301-3.
Chowdhury R, Masum A, Farazi MZ, Jahan I. The impact of predictive analytics on financial risk management in businesses. World Journal of Advanced Research and Reviews. 2024;23:1378-86.
Sun J, Perraillon MC, Myerson R. The Impact of Medicare Health Insurance Coverage on Lung Cancer Screening. Med Care. 2022;60(1):29-36.
Khiewngam K, Oranratnachai S, Kamprerasart K, Kunakorntham P, Sanvarinda P, Trachu N, et al. Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients. Front Oncol. 2023;13: 1047644.
Fang S, Wang Z. EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer. Drug Des Devel Ther. 2014;8:1595-611.
Rajyaguru D, Park M, Awais O, Krauze MT. The impact of insurance and race on non-small cell lung cancer outcomes. Journal of Clinical Oncology. 2015; 33(15_suppl):e17606-e.